Release Summary

Corgenix Medical Corporation has received U.S. FDA emergency use authorization (EUA) of its ReEBOV™ Antigen Rapid Test, the first-ever Ebola rapid diagnostic test to be approved by the FDA.

Corgenix Medical Corporation